Enhanced process increases manufacturing productivity and frees up capacity to support growing demand across Alvotech’s ...
The FDA has outlined a process for allowing a single application to cover multiple variants of a gene therapy. At the same ...
Alvotech shares rose after the company said the Food and Drug Administration approved a new manufacturing process for Simlandi, its biosimilar to Humira. The stock was 8% higher, at $5.41, in morning ...
Alvotech shares rose more than 6% in premarket trading Tuesday after the U.S. Food and Drug Administration approved a new manufacturing process for Simlandi, the company’s biosimilar to Humira.
Clene Nanomedicine has submitted an application to the U.S. Food and Drug Administration (FDA) seeking accelerated approval of its experimental oral therapy CNM-Au8 for people with amyotrophic lateral ...
The target population is adult immunocompromised patients with HSV mucocutaneous lesions that are refractory to treatment ...
A CHQPR analysis identifies 84 Texas rural hospitals at risk of closing, including 26 facing immediate risk, potentially putting emergency, maternity and inpatient services farther away. Harkla ...
GoodRx reports that FDA-approved peptides have undergone safety and effectiveness testing, while unapproved wellness peptides ...
The U.S. Food and Drug Administration (FDA) on Thursday granted accelerated approval to AstraZeneca Plc’s AZN Ultomiris ...
Enhanced process increases manufacturing productivity and frees up capacity to support growing demand across Alvotech's biosimilars portfolio REYKJAVIK, Iceland and LONDON, UK (October 20, 2026) - Alv ...